Kretschmer, L., Ruhnke, L., Schliemann, C., Fransecky, L., Steffen, B., Kaufmann, M., . . . Röllig, C. (2025). VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML. Annals of hematology, 104(7), . https://doi.org/10.1007/s00277-025-06496-7
Chicago-Zitierstil (17. Ausg.)Kretschmer, Lydia, et al. "VINCENT: A Randomized-controlled Trial Evaluating Venetoclax Plus Azacitidine Versus Intensive Chemotherapy in Patients with Newly Diagnosed, NPM1-mutated AML." Annals of Hematology 104, no. 7 (2025). https://doi.org/10.1007/s00277-025-06496-7.
MLA-Zitierstil (9. Ausg.)Kretschmer, Lydia, et al. "VINCENT: A Randomized-controlled Trial Evaluating Venetoclax Plus Azacitidine Versus Intensive Chemotherapy in Patients with Newly Diagnosed, NPM1-mutated AML." Annals of Hematology, vol. 104, no. 7, 2025, https://doi.org/10.1007/s00277-025-06496-7.